Eydenzelt
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Eydenzelt, covering 2025-12-10 to 2026-07-01. Get the full timeline:
Most recent: EMA Authorised: Eydenzelt (aflibercept) — Celltrion Healthcare Hungary Kft.